InvestorsHub Logo
Followers 126
Posts 28942
Boards Moderated 0
Alias Born 01/21/2006

Re: None

Thursday, 05/18/2017 9:40:08 AM

Thursday, May 18, 2017 9:40:08 AM

Post# of 402794
Good NEWS...Cellceutix Completes Patient Enrollment of Final Cohort in Phase 2 Trial of Brilacidin for Inflammatory Bowel Disease; Topline Results Anticipated 

https://finance.yahoo.com/news/cellceutix-completes-patient-enrollment-final-133000486.html

Always do sober what you said you'd do drunk. That will teach you to keep your mouth shut.”
? Ernest Hemingway

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News